ACRIVON THERAPEUTICS INC (ACRV:NASDAQ)

$1.51 -0.06 (-3.8217%)

watchlist-icon
search-icon
Profile Icon

Most Recent Average Sentiment Analysis Score (0 to 100): 82

negative-sentiment
Negative [0, 35)
neutral-sentiment
Neutral [35, 65]
positive-sentiment
Positive (65, 100]
Visualize Sentiment Trendline

Analysed ACRIVON THERAPEUTICS INC (ACRV:NASDAQ) News Sources

Key Opinion Leader (KOL) Panel to Discuss Acrivon’s ACR-368 Endometrial Cancer (EC) Trial during the 2026 European Society of Gynecological Oncology (ESGO) Congress

23-02-2026

yahoo.com

Acrivon Therapeutics to Present at the TD Cowen 46th Annual Health Care Conference

24-02-2026

yahoo.com

Acrivon Therapeutics Conference Highlights ACR-368 Phase 2B Data, 52% ORR in Serous Endometrial Cancer

27-02-2026

marketbeat.com

Acrivon Therapeutics, Inc. (ACRV) Upgraded to Buy: Here's Why

03-03-2026

yahoo.com

Acrivon Therapeutics to Present Pre-Clinical AP3 Data at the 2026 AACR Annual Meeting Revealing Strong Synergy of ACR-368 with ADC Topo 1 Inhibitor Payloads and of both ACR-368 and ACR-2316 with Immune Checkpoint Inhibitors

17-03-2026

yahoo.com

Acrivon Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Recent Business Highlights

19-03-2026

yahoo.com

Acrivon to Highlight Preclinical Data with Three Posters at AACR Demonstrating Strong ACR-368 and ACR-2316 Synergies with Immune Checkpoint Inhibitors and ADC Payloads, Revealing Broad Clinical Development Opportunities

17-04-2026

yahoo.com

Acrivon Reports First Quarter 2026 Financial Results and Highlights Progress Towards Key 2026 Clinical Catalysts

13-05-2026

yahoo.com

Acrivon Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

15-05-2026

yahoo.com

Acrivon Therapeutics to Present at TD Cowen’s 7th Annual Oncology Innovation Summit

21-05-2026

yahoo.com

ACRIVON THERAPEUTICS INC (ACRV:NASDAQ) Sentiment Trend

0 25 50 75 100 69 90 83 89 78 70 81 86 82 90 23-02-2026 24-02-2026 27-02-2026 03-03-2026 17-03-2026 19-03-2026 17-04-2026 13-05-2026 15-05-2026 21-05-2026 #1 #2 #3 #4 #5 #6 #7 #8 #9 #10 Negative < 35 Neutral 35–65 Positive > 65 View FAQ

ACRIVON THERAPEUTICS INC (ACRV:NASDAQ) FAQs

toggle

What is the current price of ACRIVON THERAPEUTICS INC (ACRV:NASDAQ)?

The current price of ACRIVON THERAPEUTICS INC (ACRV:NASDAQ) is $1.51.


toggle

ACRIVON THERAPEUTICS INC (ACRV:NASDAQ) absolute price change since previous trading day?

The absolute price change of ACRIVON THERAPEUTICS INC (ACRV:NASDAQ) since the previous trading day is $-0.06.


toggle

ACRIVON THERAPEUTICS INC (ACRV:NASDAQ) percentage price change since previous trading day?

The percentage price change of ACRIVON THERAPEUTICS INC (ACRV:NASDAQ) since the previous trading day is -3.8217%.


toggle

What is the most recent average sentiment score for ACRIVON THERAPEUTICS INC (ACRV:NASDAQ)?

The most recent average sentiment score for ACRIVON THERAPEUTICS INC (ACRV:NASDAQ) is 82 out of 100.


toggle

What is the most recent average sentiment for ACRIVON THERAPEUTICS INC (ACRV:NASDAQ)?

The most recent sentiment for ACRIVON THERAPEUTICS INC (ACRV:NASDAQ) is .


SEC-8K** Filing Available For ACRIVON THERAPEUTICS INC (ACRV:NASDAQ)

** material developments that could impact a company's financial condition or stock price.

Author: MattELab

X Icon

GitHub Icon

MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.